Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
455.3 USD | +2.74% | -0.35% | +11.91% |
May. 31 | BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480 | MT |
May. 31 | Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing | MT |
Official Publications
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Official Publications